The project offers an ideal opportunity for graduates with an interest in the application of AI in biology and medicine to gain experience in development of open-source platforms and to work with industrial partners to apply them to real-world challenges.
It is based on Imaging flow cytometry, an analytical technique which delivers images of millions of cells, within a few minutes of measurement. As it is able to both mass-image large populations and resolve sub-cellular image detail, it is a transformative technology for the diagnosis and monitoring of a host of diseases. This project will use the latest algorithms in AI to analyse the large datasets generated using this system and will involve collaboration with a number of clinical and industrial collaborators, and in particular Glaxo SmithKline’s pharmaceutical assessment teams.